The ABIMPROSYC line has been developed to support complex physiological processes through a structured biostructural framework. Its architecture operates without pharmacodynamic interference and without therapeutic intent.
Each formulation integrates coordinated families of compounds compatible with defined molecular pathways, organized to modulate key domains of:
Advanced immunonutrition
Mitochondrial longevity
Redox equilibrium
Adaptive recovery
Applications are not defined by medical diagnosis. Instead, they are guided by:
The user’s functional profile
Environmental and physiological load
Recovery capacity
Goals related to sustained metabolic resilience
Each variant follows a structured intervention model that enables cross-domain physiological support while remaining outside clinical territory.
Functional Immunocellular Support
ABIMPROSYC T-DEFENSE
ABIMPROSYC T-DEFENSE is designed for individuals experiencing elevated immune demand or structural recovery phases.
Compatible Functional Profiles
Elevated immune load
Post-intensive physiological treatments
Compensated immunometabolic imbalance
Accelerated immunosenescence patterns
Prolonged structural fatigue
Slow functional recovery cycles
Family history of complex cellular processes
The framework supports immunocellular resilience without therapeutic positioning.
Biostructural Axes
Activation of intracellular regulatory pathways such as Nrf2 / SIRT1
Regulation of immune microenvironment dynamics (CD8⁺ / MHC-I compatibility)
Optimization of non-pharmacological adaptive surveillance
Mitochondrial redox stabilization with sustained functional recovery
Structural Inflammatory Support
ABIMPROSYC REGENERA
ABIMPROSYC REGENERA is formulated for individuals exposed to persistent low-grade inflammatory environments requiring structural restoration without immunosuppression.
Compatible Functional Profiles
Ongoing low-grade inflammatory load
Stabilized autoimmunity requiring structural support
Slow connective or epithelial repair
Imbalance in the mucosal–immune axis
Digestive, joint, or epithelial vulnerability
The objective is structural equilibrium, not pharmacological inhibition.
Biostructural Axes
Modulation compatibility with chronic proinflammatory pathways (NF-κB, COX-2, NLRP3)
Support of endogenous antioxidant systems (GSH, catalase, SOD)
Intestinal symbiotic synchronization using encapsulated strains
Integration of structural peptides and cofactors (collagen, zinc, magnesium)
Bioadaptive Longevity Support
ABIMPROSYC VITALIS
ABIMPROSYC VITALIS is designed for functional adults experiencing progressive bioenergetic decline or markers associated with accelerated aging.
Compatible Functional Profiles
Loss of basal energy
Irregular sleep patterns
Reduced cognitive clarity
Signs of metabolic inefficiency
Early biofunctional aging indicators
Its biphasic AM/PM architecture aligns compound intake with circadian mitochondrial rhythm, supporting recovery of high-turnover systems.
Biostructural Axes
Increased intracellular availability of NAD⁺ precursors (NR)
Synchronized mitochondrial biogenesis via PQQ and CoQ10
Regulation of the melatonin–GABA axis for nighttime repair
Epigenetic preservation and cognitive plasticity support
Neuroenergetic and Performance Support
ABIMPROSYC SPORT
ABIMPROSYC SPORT is developed for individuals under high physical or neurocognitive demand who require structured activation-recovery modulation without stimulant dependency.
Compatible Functional Profiles
High physical workload
Elevated neurocognitive stress
Post-exertion recovery phases
Accumulated fatigue
Decline in functional performance without structural pathology
The formula modulates the activation–recovery axis through adaptogenic, mitochondrial, and neuromodulatory components.
Biostructural Axes
Mitochondrial stimulation and intracellular fatty acid transport optimization
Post-exertion redox regulation (MSM, NAC, astaxanthin)
Neuroendocrine balance with GABA and ashwagandha
Circadian synchronization of deep recovery cycles
Structured Multi-Domain Architecture
All ABIMPROSYC variants operate under the same Fourth Generation nutraceutical framework:
Multiphasic delivery systems
Chronoadaptive sequencing
Functional family validation
Structural compatibility logic
Regulatory-aligned positioning
They do not function as pharmaceutical agents.
They do not replace medical treatment.
They are designed to support complex physiological environments through coordinated biofunctional architecture — prioritizing resilience, recovery, and structural coherence.



